U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2009
359
Name Type Language
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
Common Name English
CYTOGAM
Brand Name English
IVEGAM-CMV
Brand Name English
IMMUNOENDOCIG
Brand Name English
CYTOMEGALOVIRUS IMMUNOGLOBULINS
MART.  
Common Name English
CYTOGLOBIN
Brand Name English
CYTOMEGALOVIRUS IMMUNE GLOBULIN
VANDF  
Common Name English
CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMAN
Common Name English
CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
Common Name English
CYTOMEGALOVIRUS IMMUNE GLOBULIN (HUMAN)
Common Name English
CYTOMEGALOVIRUS IMMUNOGLOBULINS [MART.]
Common Name English
MEGALOTECT
Brand Name English
CYTOMEGALOVIRUS IMMUNE GLOBULIN [VANDF]
Common Name English
CYTOMEGALOVIRUS IMMUNE GLOBULIN IV HUMAN
Common Name English
CYTOTECT
Brand Name English
CMV IMMUNOGLOBULIN
Brand Name English
GLOBUMAN IV CMV
Brand Name English
CYTOMEGALOVIRUS IMMUNOGLOBULIN INTRAVENOUS (HUMAN)
Common Name English
CMV IVEEGAM
Brand Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 15386
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
FDA ORPHAN DRUG 52190
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
NDF-RT N0000184165
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
EU-Orphan Drug EU/3/06/408
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
NCI_THESAURUS C2701
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
Code System Code Type Description
NDF-RT
N0000007920
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY Immunoglobulins [Chemical/Ingredient]
NCI_THESAURUS
C80826
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
DRUG BANK
DB13886
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
FDA UNII
129L90A25N
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
RXCUI
22178
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
ALTERNATIVE RxNorm
NDF-RT
N0000184009
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY Virus Neutralization [MoA]
RXCUI
1997443
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
DAILYMED
129L90A25N
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
NDF-RT
N0000183365
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY Passively Acquired Immunity [PE]
NDF-RT
N0000184152
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY Virus-specific Hyperimmune Globulins [Chemical/Ingredient]
EVMPD
SUB128472
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
CAS
339086-15-6
Created by admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966